Cargando…
Outcome measures assisting treatment optimization in multiple sclerosis
OBJECTIVE: To review instruments used to assess disease stability or progression in persons with multiple sclerosis (pwMS) that can guide clinicians in optimizing therapy. METHODS: A non-systematic review of scientific literature was undertaken to explore modalities of monitoring symptoms and the di...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8857110/ https://www.ncbi.nlm.nih.gov/pubmed/34338857 http://dx.doi.org/10.1007/s00415-021-10674-8 |
_version_ | 1784653973752381440 |
---|---|
author | Pardo, Gabriel Coates, Samantha Okuda, Darin T. |
author_facet | Pardo, Gabriel Coates, Samantha Okuda, Darin T. |
author_sort | Pardo, Gabriel |
collection | PubMed |
description | OBJECTIVE: To review instruments used to assess disease stability or progression in persons with multiple sclerosis (pwMS) that can guide clinicians in optimizing therapy. METHODS: A non-systematic review of scientific literature was undertaken to explore modalities of monitoring symptoms and the disease evolution of MS. RESULTS: Multiple outcome measures, or tools, have been developed for use in MS research as well as for the clinical management of pwMS. Beginning with the Expanded Disability Status Scale, introduced in 1983, clinicians and researchers have developed monitoring modalities to assess all aspects of MS and the neurological impairment it causes. CONCLUSIONS: Much progress has been made in recent decades for the management of MS and for the evaluation of disease progression. New technology, such as wearable sensors, will provide new opportunities to better understand changes in function, dexterity, and cognition. Essential work over the decades since EDSS was introduced continues to improve our ability to treat this debilitating disease. |
format | Online Article Text |
id | pubmed-8857110 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Springer Berlin Heidelberg |
record_format | MEDLINE/PubMed |
spelling | pubmed-88571102022-02-23 Outcome measures assisting treatment optimization in multiple sclerosis Pardo, Gabriel Coates, Samantha Okuda, Darin T. J Neurol Review OBJECTIVE: To review instruments used to assess disease stability or progression in persons with multiple sclerosis (pwMS) that can guide clinicians in optimizing therapy. METHODS: A non-systematic review of scientific literature was undertaken to explore modalities of monitoring symptoms and the disease evolution of MS. RESULTS: Multiple outcome measures, or tools, have been developed for use in MS research as well as for the clinical management of pwMS. Beginning with the Expanded Disability Status Scale, introduced in 1983, clinicians and researchers have developed monitoring modalities to assess all aspects of MS and the neurological impairment it causes. CONCLUSIONS: Much progress has been made in recent decades for the management of MS and for the evaluation of disease progression. New technology, such as wearable sensors, will provide new opportunities to better understand changes in function, dexterity, and cognition. Essential work over the decades since EDSS was introduced continues to improve our ability to treat this debilitating disease. Springer Berlin Heidelberg 2021-08-02 2022 /pmc/articles/PMC8857110/ /pubmed/34338857 http://dx.doi.org/10.1007/s00415-021-10674-8 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Review Pardo, Gabriel Coates, Samantha Okuda, Darin T. Outcome measures assisting treatment optimization in multiple sclerosis |
title | Outcome measures assisting treatment optimization in multiple sclerosis |
title_full | Outcome measures assisting treatment optimization in multiple sclerosis |
title_fullStr | Outcome measures assisting treatment optimization in multiple sclerosis |
title_full_unstemmed | Outcome measures assisting treatment optimization in multiple sclerosis |
title_short | Outcome measures assisting treatment optimization in multiple sclerosis |
title_sort | outcome measures assisting treatment optimization in multiple sclerosis |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8857110/ https://www.ncbi.nlm.nih.gov/pubmed/34338857 http://dx.doi.org/10.1007/s00415-021-10674-8 |
work_keys_str_mv | AT pardogabriel outcomemeasuresassistingtreatmentoptimizationinmultiplesclerosis AT coatessamantha outcomemeasuresassistingtreatmentoptimizationinmultiplesclerosis AT okudadarint outcomemeasuresassistingtreatmentoptimizationinmultiplesclerosis |